Global Medical Fluorescence Imaging Agent Market Growth 2026-2032
The global Medical Fluorescence Imaging Agent market size is predicted to grow from US$ 1327 million in 2025 to US$ 1832 million in 2032; it is expected to grow at a CAGR of 4.8% from 2026 to 2032.
Medical fluorescence imaging agents, also known as fluorescent contrast agents or fluorophores, are diagnostic compounds that emit fluorescence upon excitation by specific wavelengths of light, enabling real-time visualization of anatomical structures, pathological lesions, and physiological processes during medical imaging procedures. These agents are widely used in fluorescence-guided surgery, angiography, sentinel lymph node biopsy, and intraoperative tumor detection. Fluorescence imaging agents can be broadly categorized into non-targeted agents (which passively distribute in tissues) and targeted molecular probes (which bind to specific biomarkers). The global average selling price for medical fluorescence imaging agents is approximately US$82 per unit. The average sales volume in the base year is estimated at 16,548k units. The industry average gross margin is approximately 50%, with typical ranges between 40% and 60%, reflecting the high-value, research-intensive nature of these diagnostic products. The upstream segment includes manufacturers of fluorophore raw materials, chemical synthesis intermediates, and pharmaceutical-grade excipients. The midstream segment comprises imaging agent manufacturers that formulate, synthesize, and distribute finished products. The downstream segment encompasses hospitals, surgical centers, diagnostic imaging facilities, and research institutions that utilize these agents for fluorescence-guided surgery, angiography, cancer detection, and various diagnostic applications.
The medical fluorescence imaging agent market is undergoing significant transformation driven by the convergence of surgical precision demands, technological innovation, and regulatory approvals for novel targeted agents. The industry is witnessing a fundamental shift from non-specific, passive dyes to highly specific targeted molecular probes that enable precise tumor visualization, improved margin delineation, and detection of occult lesions. This evolution reflects a broader trend toward precision medicine in surgery, where imaging tools are increasingly tailored to disease-specific biomarkers and patient-specific needs.
The growing adoption of fluorescence-guided surgery (FGS) across multiple surgical specialties is a primary market driver. The increasing demand for surgical precision has driven the clinical adoption of contrast agents with improved specificity, safety, and efficacy. Seven FDA-approved intraoperative fluorescence contrast agents—Indocyanine Green (ICG), Fluorescein Sodium, 5-Aminolevulinic Acid (5-ALA), Methylene Blue (MB), Cysview (Hexaminolevulinate), Cytalux (OTL38/ Pafolacianine), and Pegulicianine (LUMISIGHT™)—are now available for clinical use.
LP Information, Inc. (LPI) ' newest research report, the “Medical Fluorescence Imaging Agent Industry Forecast” looks at past sales and reviews total world Medical Fluorescence Imaging Agent sales in 2025, providing a comprehensive analysis by region and market sector of projected Medical Fluorescence Imaging Agent sales for 2026 through 2032. With Medical Fluorescence Imaging Agent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Fluorescence Imaging Agent industry.
This Insight Report provides a comprehensive analysis of the global Medical Fluorescence Imaging Agent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Fluorescence Imaging Agent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Fluorescence Imaging Agent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Fluorescence Imaging Agent and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Fluorescence Imaging Agent.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Fluorescence Imaging Agent market by product type, application, key manufacturers and key regions and countries.
Medical fluorescence imaging agents, also known as fluorescent contrast agents or fluorophores, are diagnostic compounds that emit fluorescence upon excitation by specific wavelengths of light, enabling real-time visualization of anatomical structures, pathological lesions, and physiological processes during medical imaging procedures. These agents are widely used in fluorescence-guided surgery, angiography, sentinel lymph node biopsy, and intraoperative tumor detection. Fluorescence imaging agents can be broadly categorized into non-targeted agents (which passively distribute in tissues) and targeted molecular probes (which bind to specific biomarkers). The global average selling price for medical fluorescence imaging agents is approximately US$82 per unit. The average sales volume in the base year is estimated at 16,548k units. The industry average gross margin is approximately 50%, with typical ranges between 40% and 60%, reflecting the high-value, research-intensive nature of these diagnostic products. The upstream segment includes manufacturers of fluorophore raw materials, chemical synthesis intermediates, and pharmaceutical-grade excipients. The midstream segment comprises imaging agent manufacturers that formulate, synthesize, and distribute finished products. The downstream segment encompasses hospitals, surgical centers, diagnostic imaging facilities, and research institutions that utilize these agents for fluorescence-guided surgery, angiography, cancer detection, and various diagnostic applications.
The medical fluorescence imaging agent market is undergoing significant transformation driven by the convergence of surgical precision demands, technological innovation, and regulatory approvals for novel targeted agents. The industry is witnessing a fundamental shift from non-specific, passive dyes to highly specific targeted molecular probes that enable precise tumor visualization, improved margin delineation, and detection of occult lesions. This evolution reflects a broader trend toward precision medicine in surgery, where imaging tools are increasingly tailored to disease-specific biomarkers and patient-specific needs.
The growing adoption of fluorescence-guided surgery (FGS) across multiple surgical specialties is a primary market driver. The increasing demand for surgical precision has driven the clinical adoption of contrast agents with improved specificity, safety, and efficacy. Seven FDA-approved intraoperative fluorescence contrast agents—Indocyanine Green (ICG), Fluorescein Sodium, 5-Aminolevulinic Acid (5-ALA), Methylene Blue (MB), Cysview (Hexaminolevulinate), Cytalux (OTL38/ Pafolacianine), and Pegulicianine (LUMISIGHT™)—are now available for clinical use.
LP Information, Inc. (LPI) ' newest research report, the “Medical Fluorescence Imaging Agent Industry Forecast” looks at past sales and reviews total world Medical Fluorescence Imaging Agent sales in 2025, providing a comprehensive analysis by region and market sector of projected Medical Fluorescence Imaging Agent sales for 2026 through 2032. With Medical Fluorescence Imaging Agent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Fluorescence Imaging Agent industry.
This Insight Report provides a comprehensive analysis of the global Medical Fluorescence Imaging Agent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Fluorescence Imaging Agent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Fluorescence Imaging Agent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Fluorescence Imaging Agent and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Fluorescence Imaging Agent.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Fluorescence Imaging Agent market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Non-Targeted (Passive) Agents
- Targeted Molecular Probes
- Activatable / Smart Probes
Segmentation by Fluorophore Type:
- Visible-Light Fluorophores
- Near-Infrared (NIR) Fluorophores
Segmentation by Imaging Wavelength:
- Visible-Light Imaging (400–700 nm)
- Near-Infrared I (700–900 nm)
- Near-Infrared II (1000–1700 nm)
Segmentation by Application:
- Hospitals & Surgical Centers
- Diagnostic Imaging Facilities
- Research Institutions
- Pharmaceutical R&D Laboratories
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GE Healthcare
- Bayer AG
- Siemens Healthineers
- Bracco Imaging S.p.A.
- Guerbet Group
- Lantheus Medical Imaging
- Thermo Fisher Scientific
- PerkinElmer, Inc.
- Akorn, Inc.
- Nanopet Pharma GmbH
- CMC Contrast AB
- Daiichi Sankyo
- Spago Nanomedical AB
- LI-COR Biosciences
- BD (Becton, Dickinson and Company)
- Merck KGaA
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Medical Fluorescence Imaging Agent market?
- What factors are driving Medical Fluorescence Imaging Agent market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Medical Fluorescence Imaging Agent market opportunities vary by end market size?
- How does Medical Fluorescence Imaging Agent break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Medical Fluorescence Imaging Agent Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Medical Fluorescence Imaging Agent by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Medical Fluorescence Imaging Agent by Country/Region, 2021, 2025 & 2032
2.2 Medical Fluorescence Imaging Agent Segment by Type
2.2.1 Non-Targeted (Passive) Agents
2.2.2 Targeted Molecular Probes
2.2.3 Activatable / Smart Probes
2.2.4 Medical Fluorescence Imaging Agent Sales by Type
2.2.4.1 Global Medical Fluorescence Imaging Agent Sales Market Share by Type (2021-2026)
2.2.4.2 Global Medical Fluorescence Imaging Agent Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Medical Fluorescence Imaging Agent Sale Price by Type (2021-2026)
2.3 Medical Fluorescence Imaging Agent Segment by Fluorophore Type
2.3.1 Visible-Light Fluorophores
2.3.2 Near-Infrared (NIR) Fluorophores
2.3.3 Medical Fluorescence Imaging Agent Sales by Fluorophore Type
2.3.3.1 Global Medical Fluorescence Imaging Agent Sales Market Share by Fluorophore Type (2021-2026)
2.3.3.2 Global Medical Fluorescence Imaging Agent Revenue and Market Share by Fluorophore Type (2021-2026)
2.3.3.3 Global Medical Fluorescence Imaging Agent Sale Price by Fluorophore Type (2021-2026)
2.4 Medical Fluorescence Imaging Agent Segment by Imaging Wavelength
2.4.1 Visible-Light Imaging (400–700 nm)
2.4.2 Near-Infrared I (700–900 nm)
2.4.3 Near-Infrared II (1000–1700 nm)
2.4.4 Medical Fluorescence Imaging Agent Sales by Imaging Wavelength
2.4.4.1 Global Medical Fluorescence Imaging Agent Sales Market Share by Imaging Wavelength (2021-2026)
2.4.4.2 Global Medical Fluorescence Imaging Agent Revenue and Market Share by Imaging Wavelength (2021-2026)
2.4.4.3 Global Medical Fluorescence Imaging Agent Sale Price by Imaging Wavelength (2021-2026)
2.5 Medical Fluorescence Imaging Agent Segment by Application
2.5.1 Hospitals & Surgical Centers
2.5.2 Diagnostic Imaging Facilities
2.5.3 Research Institutions
2.5.4 Pharmaceutical R&D Laboratories
2.5.5 Medical Fluorescence Imaging Agent Sales by Application
2.5.5.1 Global Medical Fluorescence Imaging Agent Sale Market Share by Application (2021-2026)
2.5.5.2 Global Medical Fluorescence Imaging Agent Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Medical Fluorescence Imaging Agent Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Medical Fluorescence Imaging Agent Breakdown Data by Company
3.1.1 Global Medical Fluorescence Imaging Agent Annual Sales by Company (2021-2026)
3.1.2 Global Medical Fluorescence Imaging Agent Sales Market Share by Company (2021-2026)
3.2 Global Medical Fluorescence Imaging Agent Annual Revenue by Company (2021-2026)
3.2.1 Global Medical Fluorescence Imaging Agent Revenue by Company (2021-2026)
3.2.2 Global Medical Fluorescence Imaging Agent Revenue Market Share by Company (2021-2026)
3.3 Global Medical Fluorescence Imaging Agent Sale Price by Company
3.4 Key Manufacturers Medical Fluorescence Imaging Agent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Fluorescence Imaging Agent Product Location Distribution
3.4.2 Players Medical Fluorescence Imaging Agent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MEDICAL FLUORESCENCE IMAGING AGENT BY GEOGRAPHIC REGION
4.1 World Historic Medical Fluorescence Imaging Agent Market Size by Geographic Region (2021-2026)
4.1.1 Global Medical Fluorescence Imaging Agent Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Medical Fluorescence Imaging Agent Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Medical Fluorescence Imaging Agent Market Size by Country/Region (2021-2026)
4.2.1 Global Medical Fluorescence Imaging Agent Annual Sales by Country/Region (2021-2026)
4.2.2 Global Medical Fluorescence Imaging Agent Annual Revenue by Country/Region (2021-2026)
4.3 Americas Medical Fluorescence Imaging Agent Sales Growth
4.4 APAC Medical Fluorescence Imaging Agent Sales Growth
4.5 Europe Medical Fluorescence Imaging Agent Sales Growth
4.6 Middle East & Africa Medical Fluorescence Imaging Agent Sales Growth
5 AMERICAS
5.1 Americas Medical Fluorescence Imaging Agent Sales by Country
5.1.1 Americas Medical Fluorescence Imaging Agent Sales by Country (2021-2026)
5.1.2 Americas Medical Fluorescence Imaging Agent Revenue by Country (2021-2026)
5.2 Americas Medical Fluorescence Imaging Agent Sales by Type (2021-2026)
5.3 Americas Medical Fluorescence Imaging Agent Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Fluorescence Imaging Agent Sales by Region
6.1.1 APAC Medical Fluorescence Imaging Agent Sales by Region (2021-2026)
6.1.2 APAC Medical Fluorescence Imaging Agent Revenue by Region (2021-2026)
6.2 APAC Medical Fluorescence Imaging Agent Sales by Type (2021-2026)
6.3 APAC Medical Fluorescence Imaging Agent Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Medical Fluorescence Imaging Agent by Country
7.1.1 Europe Medical Fluorescence Imaging Agent Sales by Country (2021-2026)
7.1.2 Europe Medical Fluorescence Imaging Agent Revenue by Country (2021-2026)
7.2 Europe Medical Fluorescence Imaging Agent Sales by Type (2021-2026)
7.3 Europe Medical Fluorescence Imaging Agent Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Medical Fluorescence Imaging Agent by Country
8.1.1 Middle East & Africa Medical Fluorescence Imaging Agent Sales by Country (2021-2026)
8.1.2 Middle East & Africa Medical Fluorescence Imaging Agent Revenue by Country (2021-2026)
8.2 Middle East & Africa Medical Fluorescence Imaging Agent Sales by Type (2021-2026)
8.3 Middle East & Africa Medical Fluorescence Imaging Agent Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Fluorescence Imaging Agent
10.3 Manufacturing Process Analysis of Medical Fluorescence Imaging Agent
10.4 Industry Chain Structure of Medical Fluorescence Imaging Agent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Fluorescence Imaging Agent Distributors
11.3 Medical Fluorescence Imaging Agent Customer
12 WORLD FORECAST REVIEW FOR MEDICAL FLUORESCENCE IMAGING AGENT BY GEOGRAPHIC REGION
12.1 Global Medical Fluorescence Imaging Agent Market Size Forecast by Region
12.1.1 Global Medical Fluorescence Imaging Agent Forecast by Region (2027-2032)
12.1.2 Global Medical Fluorescence Imaging Agent Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Medical Fluorescence Imaging Agent Forecast by Type (2027-2032)
12.7 Global Medical Fluorescence Imaging Agent Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 GE Healthcare
13.1.1 GE Healthcare Company Information
13.1.2 GE Healthcare Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.1.3 GE Healthcare Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 GE Healthcare Main Business Overview
13.1.5 GE Healthcare Latest Developments
13.2 Bayer AG
13.2.1 Bayer AG Company Information
13.2.2 Bayer AG Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.2.3 Bayer AG Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Bayer AG Main Business Overview
13.2.5 Bayer AG Latest Developments
13.3 Siemens Healthineers
13.3.1 Siemens Healthineers Company Information
13.3.2 Siemens Healthineers Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.3.3 Siemens Healthineers Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Siemens Healthineers Main Business Overview
13.3.5 Siemens Healthineers Latest Developments
13.4 Bracco Imaging S.p.A.
13.4.1 Bracco Imaging S.p.A. Company Information
13.4.2 Bracco Imaging S.p.A. Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.4.3 Bracco Imaging S.p.A. Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bracco Imaging S.p.A. Main Business Overview
13.4.5 Bracco Imaging S.p.A. Latest Developments
13.5 Guerbet Group
13.5.1 Guerbet Group Company Information
13.5.2 Guerbet Group Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.5.3 Guerbet Group Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Guerbet Group Main Business Overview
13.5.5 Guerbet Group Latest Developments
13.6 Lantheus Medical Imaging
13.6.1 Lantheus Medical Imaging Company Information
13.6.2 Lantheus Medical Imaging Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.6.3 Lantheus Medical Imaging Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Lantheus Medical Imaging Main Business Overview
13.6.5 Lantheus Medical Imaging Latest Developments
13.7 Thermo Fisher Scientific
13.7.1 Thermo Fisher Scientific Company Information
13.7.2 Thermo Fisher Scientific Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.7.3 Thermo Fisher Scientific Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Thermo Fisher Scientific Main Business Overview
13.7.5 Thermo Fisher Scientific Latest Developments
13.8 PerkinElmer, Inc.
13.8.1 PerkinElmer, Inc. Company Information
13.8.2 PerkinElmer, Inc. Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.8.3 PerkinElmer, Inc. Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 PerkinElmer, Inc. Main Business Overview
13.8.5 PerkinElmer, Inc. Latest Developments
13.9 Akorn, Inc.
13.9.1 Akorn, Inc. Company Information
13.9.2 Akorn, Inc. Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.9.3 Akorn, Inc. Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Akorn, Inc. Main Business Overview
13.9.5 Akorn, Inc. Latest Developments
13.10 Nanopet Pharma GmbH
13.10.1 Nanopet Pharma GmbH Company Information
13.10.2 Nanopet Pharma GmbH Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.10.3 Nanopet Pharma GmbH Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Nanopet Pharma GmbH Main Business Overview
13.10.5 Nanopet Pharma GmbH Latest Developments
13.11 CMC Contrast AB
13.11.1 CMC Contrast AB Company Information
13.11.2 CMC Contrast AB Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.11.3 CMC Contrast AB Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 CMC Contrast AB Main Business Overview
13.11.5 CMC Contrast AB Latest Developments
13.12 Daiichi Sankyo
13.12.1 Daiichi Sankyo Company Information
13.12.2 Daiichi Sankyo Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.12.3 Daiichi Sankyo Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Daiichi Sankyo Main Business Overview
13.12.5 Daiichi Sankyo Latest Developments
13.13 Spago Nanomedical AB
13.13.1 Spago Nanomedical AB Company Information
13.13.2 Spago Nanomedical AB Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.13.3 Spago Nanomedical AB Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Spago Nanomedical AB Main Business Overview
13.13.5 Spago Nanomedical AB Latest Developments
13.14 LI-COR Biosciences
13.14.1 LI-COR Biosciences Company Information
13.14.2 LI-COR Biosciences Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.14.3 LI-COR Biosciences Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 LI-COR Biosciences Main Business Overview
13.14.5 LI-COR Biosciences Latest Developments
13.15 BD (Becton, Dickinson and Company)
13.15.1 BD (Becton, Dickinson and Company) Company Information
13.15.2 BD (Becton, Dickinson and Company) Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.15.3 BD (Becton, Dickinson and Company) Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 BD (Becton, Dickinson and Company) Main Business Overview
13.15.5 BD (Becton, Dickinson and Company) Latest Developments
13.16 Merck KGaA
13.16.1 Merck KGaA Company Information
13.16.2 Merck KGaA Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.16.3 Merck KGaA Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Merck KGaA Main Business Overview
13.16.5 Merck KGaA Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Medical Fluorescence Imaging Agent Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Medical Fluorescence Imaging Agent by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Medical Fluorescence Imaging Agent by Country/Region, 2021, 2025 & 2032
2.2 Medical Fluorescence Imaging Agent Segment by Type
2.2.1 Non-Targeted (Passive) Agents
2.2.2 Targeted Molecular Probes
2.2.3 Activatable / Smart Probes
2.2.4 Medical Fluorescence Imaging Agent Sales by Type
2.2.4.1 Global Medical Fluorescence Imaging Agent Sales Market Share by Type (2021-2026)
2.2.4.2 Global Medical Fluorescence Imaging Agent Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Medical Fluorescence Imaging Agent Sale Price by Type (2021-2026)
2.3 Medical Fluorescence Imaging Agent Segment by Fluorophore Type
2.3.1 Visible-Light Fluorophores
2.3.2 Near-Infrared (NIR) Fluorophores
2.3.3 Medical Fluorescence Imaging Agent Sales by Fluorophore Type
2.3.3.1 Global Medical Fluorescence Imaging Agent Sales Market Share by Fluorophore Type (2021-2026)
2.3.3.2 Global Medical Fluorescence Imaging Agent Revenue and Market Share by Fluorophore Type (2021-2026)
2.3.3.3 Global Medical Fluorescence Imaging Agent Sale Price by Fluorophore Type (2021-2026)
2.4 Medical Fluorescence Imaging Agent Segment by Imaging Wavelength
2.4.1 Visible-Light Imaging (400–700 nm)
2.4.2 Near-Infrared I (700–900 nm)
2.4.3 Near-Infrared II (1000–1700 nm)
2.4.4 Medical Fluorescence Imaging Agent Sales by Imaging Wavelength
2.4.4.1 Global Medical Fluorescence Imaging Agent Sales Market Share by Imaging Wavelength (2021-2026)
2.4.4.2 Global Medical Fluorescence Imaging Agent Revenue and Market Share by Imaging Wavelength (2021-2026)
2.4.4.3 Global Medical Fluorescence Imaging Agent Sale Price by Imaging Wavelength (2021-2026)
2.5 Medical Fluorescence Imaging Agent Segment by Application
2.5.1 Hospitals & Surgical Centers
2.5.2 Diagnostic Imaging Facilities
2.5.3 Research Institutions
2.5.4 Pharmaceutical R&D Laboratories
2.5.5 Medical Fluorescence Imaging Agent Sales by Application
2.5.5.1 Global Medical Fluorescence Imaging Agent Sale Market Share by Application (2021-2026)
2.5.5.2 Global Medical Fluorescence Imaging Agent Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Medical Fluorescence Imaging Agent Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Medical Fluorescence Imaging Agent Breakdown Data by Company
3.1.1 Global Medical Fluorescence Imaging Agent Annual Sales by Company (2021-2026)
3.1.2 Global Medical Fluorescence Imaging Agent Sales Market Share by Company (2021-2026)
3.2 Global Medical Fluorescence Imaging Agent Annual Revenue by Company (2021-2026)
3.2.1 Global Medical Fluorescence Imaging Agent Revenue by Company (2021-2026)
3.2.2 Global Medical Fluorescence Imaging Agent Revenue Market Share by Company (2021-2026)
3.3 Global Medical Fluorescence Imaging Agent Sale Price by Company
3.4 Key Manufacturers Medical Fluorescence Imaging Agent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Fluorescence Imaging Agent Product Location Distribution
3.4.2 Players Medical Fluorescence Imaging Agent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MEDICAL FLUORESCENCE IMAGING AGENT BY GEOGRAPHIC REGION
4.1 World Historic Medical Fluorescence Imaging Agent Market Size by Geographic Region (2021-2026)
4.1.1 Global Medical Fluorescence Imaging Agent Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Medical Fluorescence Imaging Agent Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Medical Fluorescence Imaging Agent Market Size by Country/Region (2021-2026)
4.2.1 Global Medical Fluorescence Imaging Agent Annual Sales by Country/Region (2021-2026)
4.2.2 Global Medical Fluorescence Imaging Agent Annual Revenue by Country/Region (2021-2026)
4.3 Americas Medical Fluorescence Imaging Agent Sales Growth
4.4 APAC Medical Fluorescence Imaging Agent Sales Growth
4.5 Europe Medical Fluorescence Imaging Agent Sales Growth
4.6 Middle East & Africa Medical Fluorescence Imaging Agent Sales Growth
5 AMERICAS
5.1 Americas Medical Fluorescence Imaging Agent Sales by Country
5.1.1 Americas Medical Fluorescence Imaging Agent Sales by Country (2021-2026)
5.1.2 Americas Medical Fluorescence Imaging Agent Revenue by Country (2021-2026)
5.2 Americas Medical Fluorescence Imaging Agent Sales by Type (2021-2026)
5.3 Americas Medical Fluorescence Imaging Agent Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Fluorescence Imaging Agent Sales by Region
6.1.1 APAC Medical Fluorescence Imaging Agent Sales by Region (2021-2026)
6.1.2 APAC Medical Fluorescence Imaging Agent Revenue by Region (2021-2026)
6.2 APAC Medical Fluorescence Imaging Agent Sales by Type (2021-2026)
6.3 APAC Medical Fluorescence Imaging Agent Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Medical Fluorescence Imaging Agent by Country
7.1.1 Europe Medical Fluorescence Imaging Agent Sales by Country (2021-2026)
7.1.2 Europe Medical Fluorescence Imaging Agent Revenue by Country (2021-2026)
7.2 Europe Medical Fluorescence Imaging Agent Sales by Type (2021-2026)
7.3 Europe Medical Fluorescence Imaging Agent Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Medical Fluorescence Imaging Agent by Country
8.1.1 Middle East & Africa Medical Fluorescence Imaging Agent Sales by Country (2021-2026)
8.1.2 Middle East & Africa Medical Fluorescence Imaging Agent Revenue by Country (2021-2026)
8.2 Middle East & Africa Medical Fluorescence Imaging Agent Sales by Type (2021-2026)
8.3 Middle East & Africa Medical Fluorescence Imaging Agent Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Fluorescence Imaging Agent
10.3 Manufacturing Process Analysis of Medical Fluorescence Imaging Agent
10.4 Industry Chain Structure of Medical Fluorescence Imaging Agent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Fluorescence Imaging Agent Distributors
11.3 Medical Fluorescence Imaging Agent Customer
12 WORLD FORECAST REVIEW FOR MEDICAL FLUORESCENCE IMAGING AGENT BY GEOGRAPHIC REGION
12.1 Global Medical Fluorescence Imaging Agent Market Size Forecast by Region
12.1.1 Global Medical Fluorescence Imaging Agent Forecast by Region (2027-2032)
12.1.2 Global Medical Fluorescence Imaging Agent Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Medical Fluorescence Imaging Agent Forecast by Type (2027-2032)
12.7 Global Medical Fluorescence Imaging Agent Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 GE Healthcare
13.1.1 GE Healthcare Company Information
13.1.2 GE Healthcare Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.1.3 GE Healthcare Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 GE Healthcare Main Business Overview
13.1.5 GE Healthcare Latest Developments
13.2 Bayer AG
13.2.1 Bayer AG Company Information
13.2.2 Bayer AG Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.2.3 Bayer AG Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Bayer AG Main Business Overview
13.2.5 Bayer AG Latest Developments
13.3 Siemens Healthineers
13.3.1 Siemens Healthineers Company Information
13.3.2 Siemens Healthineers Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.3.3 Siemens Healthineers Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Siemens Healthineers Main Business Overview
13.3.5 Siemens Healthineers Latest Developments
13.4 Bracco Imaging S.p.A.
13.4.1 Bracco Imaging S.p.A. Company Information
13.4.2 Bracco Imaging S.p.A. Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.4.3 Bracco Imaging S.p.A. Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bracco Imaging S.p.A. Main Business Overview
13.4.5 Bracco Imaging S.p.A. Latest Developments
13.5 Guerbet Group
13.5.1 Guerbet Group Company Information
13.5.2 Guerbet Group Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.5.3 Guerbet Group Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Guerbet Group Main Business Overview
13.5.5 Guerbet Group Latest Developments
13.6 Lantheus Medical Imaging
13.6.1 Lantheus Medical Imaging Company Information
13.6.2 Lantheus Medical Imaging Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.6.3 Lantheus Medical Imaging Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Lantheus Medical Imaging Main Business Overview
13.6.5 Lantheus Medical Imaging Latest Developments
13.7 Thermo Fisher Scientific
13.7.1 Thermo Fisher Scientific Company Information
13.7.2 Thermo Fisher Scientific Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.7.3 Thermo Fisher Scientific Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Thermo Fisher Scientific Main Business Overview
13.7.5 Thermo Fisher Scientific Latest Developments
13.8 PerkinElmer, Inc.
13.8.1 PerkinElmer, Inc. Company Information
13.8.2 PerkinElmer, Inc. Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.8.3 PerkinElmer, Inc. Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 PerkinElmer, Inc. Main Business Overview
13.8.5 PerkinElmer, Inc. Latest Developments
13.9 Akorn, Inc.
13.9.1 Akorn, Inc. Company Information
13.9.2 Akorn, Inc. Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.9.3 Akorn, Inc. Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Akorn, Inc. Main Business Overview
13.9.5 Akorn, Inc. Latest Developments
13.10 Nanopet Pharma GmbH
13.10.1 Nanopet Pharma GmbH Company Information
13.10.2 Nanopet Pharma GmbH Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.10.3 Nanopet Pharma GmbH Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Nanopet Pharma GmbH Main Business Overview
13.10.5 Nanopet Pharma GmbH Latest Developments
13.11 CMC Contrast AB
13.11.1 CMC Contrast AB Company Information
13.11.2 CMC Contrast AB Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.11.3 CMC Contrast AB Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 CMC Contrast AB Main Business Overview
13.11.5 CMC Contrast AB Latest Developments
13.12 Daiichi Sankyo
13.12.1 Daiichi Sankyo Company Information
13.12.2 Daiichi Sankyo Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.12.3 Daiichi Sankyo Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Daiichi Sankyo Main Business Overview
13.12.5 Daiichi Sankyo Latest Developments
13.13 Spago Nanomedical AB
13.13.1 Spago Nanomedical AB Company Information
13.13.2 Spago Nanomedical AB Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.13.3 Spago Nanomedical AB Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Spago Nanomedical AB Main Business Overview
13.13.5 Spago Nanomedical AB Latest Developments
13.14 LI-COR Biosciences
13.14.1 LI-COR Biosciences Company Information
13.14.2 LI-COR Biosciences Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.14.3 LI-COR Biosciences Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 LI-COR Biosciences Main Business Overview
13.14.5 LI-COR Biosciences Latest Developments
13.15 BD (Becton, Dickinson and Company)
13.15.1 BD (Becton, Dickinson and Company) Company Information
13.15.2 BD (Becton, Dickinson and Company) Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.15.3 BD (Becton, Dickinson and Company) Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 BD (Becton, Dickinson and Company) Main Business Overview
13.15.5 BD (Becton, Dickinson and Company) Latest Developments
13.16 Merck KGaA
13.16.1 Merck KGaA Company Information
13.16.2 Merck KGaA Medical Fluorescence Imaging Agent Product Portfolios and Specifications
13.16.3 Merck KGaA Medical Fluorescence Imaging Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Merck KGaA Main Business Overview
13.16.5 Merck KGaA Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Medical Fluorescence Imaging Agent Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Medical Fluorescence Imaging Agent Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Non-Targeted (Passive) Agents
Table 4. Major Players of Targeted Molecular Probes
Table 5. Major Players of Activatable / Smart Probes
Table 6. Global Medical Fluorescence Imaging Agent Sales by Type (2021-2026) & (K Units)
Table 7. Global Medical Fluorescence Imaging Agent Sales Market Share by Type (2021-2026)
Table 8. Global Medical Fluorescence Imaging Agent Revenue by Type (2021-2026) & ($ million)
Table 9. Global Medical Fluorescence Imaging Agent Revenue Market Share by Type (2021-2026)
Table 10. Global Medical Fluorescence Imaging Agent Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Visible-Light Fluorophores
Table 12. Major Players of Near-Infrared (NIR) Fluorophores
Table 13. Global Medical Fluorescence Imaging Agent Sales by Fluorophore Type (2021-2026) & (K Units)
Table 14. Global Medical Fluorescence Imaging Agent Sales Market Share by Fluorophore Type (2021-2026)
Table 15. Global Medical Fluorescence Imaging Agent Revenue by Fluorophore Type (2021-2026) & ($ million)
Table 16. Global Medical Fluorescence Imaging Agent Revenue Market Share by Fluorophore Type (2021-2026)
Table 17. Global Medical Fluorescence Imaging Agent Sale Price by Fluorophore Type (2021-2026) & (US$/Unit)
Table 18. Major Players of Visible-Light Imaging (400–700 nm)
Table 19. Major Players of Near-Infrared I (700–900 nm)
Table 20. Major Players of Near-Infrared II (1000–1700 nm)
Table 21. Global Medical Fluorescence Imaging Agent Sales by Imaging Wavelength (2021-2026) & (K Units)
Table 22. Global Medical Fluorescence Imaging Agent Sales Market Share by Imaging Wavelength (2021-2026)
Table 23. Global Medical Fluorescence Imaging Agent Revenue by Imaging Wavelength (2021-2026) & ($ million)
Table 24. Global Medical Fluorescence Imaging Agent Revenue Market Share by Imaging Wavelength (2021-2026)
Table 25. Global Medical Fluorescence Imaging Agent Sale Price by Imaging Wavelength (2021-2026) & (US$/Unit)
Table 26. Global Medical Fluorescence Imaging Agent Sale by Application (2021-2026) & (K Units)
Table 27. Global Medical Fluorescence Imaging Agent Sale Market Share by Application (2021-2026)
Table 28. Global Medical Fluorescence Imaging Agent Revenue by Application (2021-2026) & ($ million)
Table 29. Global Medical Fluorescence Imaging Agent Revenue Market Share by Application (2021-2026)
Table 30. Global Medical Fluorescence Imaging Agent Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global Medical Fluorescence Imaging Agent Sales by Company (2021-2026) & (K Units)
Table 32. Global Medical Fluorescence Imaging Agent Sales Market Share by Company (2021-2026)
Table 33. Global Medical Fluorescence Imaging Agent Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Medical Fluorescence Imaging Agent Revenue Market Share by Company (2021-2026)
Table 35. Global Medical Fluorescence Imaging Agent Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers Medical Fluorescence Imaging Agent Producing Area Distribution and Sales Area
Table 37. Players Medical Fluorescence Imaging Agent Products Offered
Table 38. Medical Fluorescence Imaging Agent Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Medical Fluorescence Imaging Agent Sales by Geographic Region (2021-2026) & (K Units)
Table 42. Global Medical Fluorescence Imaging Agent Sales Market Share Geographic Region (2021-2026)
Table 43. Global Medical Fluorescence Imaging Agent Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Medical Fluorescence Imaging Agent Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Medical Fluorescence Imaging Agent Sales by Country/Region (2021-2026) & (K Units)
Table 46. Global Medical Fluorescence Imaging Agent Sales Market Share by Country/Region (2021-2026)
Table 47. Global Medical Fluorescence Imaging Agent Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Medical Fluorescence Imaging Agent Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Medical Fluorescence Imaging Agent Sales by Country (2021-2026) & (K Units)
Table 50. Americas Medical Fluorescence Imaging Agent Sales Market Share by Country (2021-2026)
Table 51. Americas Medical Fluorescence Imaging Agent Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Medical Fluorescence Imaging Agent Sales by Type (2021-2026) & (K Units)
Table 53. Americas Medical Fluorescence Imaging Agent Sales by Application (2021-2026) & (K Units)
Table 54. APAC Medical Fluorescence Imaging Agent Sales by Region (2021-2026) & (K Units)
Table 55. APAC Medical Fluorescence Imaging Agent Sales Market Share by Region (2021-2026)
Table 56. APAC Medical Fluorescence Imaging Agent Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Medical Fluorescence Imaging Agent Sales by Type (2021-2026) & (K Units)
Table 58. APAC Medical Fluorescence Imaging Agent Sales by Application (2021-2026) & (K Units)
Table 59. Europe Medical Fluorescence Imaging Agent Sales by Country (2021-2026) & (K Units)
Table 60. Europe Medical Fluorescence Imaging Agent Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Medical Fluorescence Imaging Agent Sales by Type (2021-2026) & (K Units)
Table 62. Europe Medical Fluorescence Imaging Agent Sales by Application (2021-2026) & (K Units)
Table 63. Middle East & Africa Medical Fluorescence Imaging Agent Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa Medical Fluorescence Imaging Agent Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Medical Fluorescence Imaging Agent Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Medical Fluorescence Imaging Agent Sales by Application (2021-2026) & (K Units)
Table 67. Key Market Drivers & Growth Opportunities of Medical Fluorescence Imaging Agent
Table 68. Key Market Challenges & Risks of Medical Fluorescence Imaging Agent
Table 69. Key Industry Trends of Medical Fluorescence Imaging Agent
Table 70. Medical Fluorescence Imaging Agent Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Medical Fluorescence Imaging Agent Distributors List
Table 73. Medical Fluorescence Imaging Agent Customer List
Table 74. Global Medical Fluorescence Imaging Agent Sales Forecast by Region (2027-2032) & (K Units)
Table 75. Global Medical Fluorescence Imaging Agent Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Medical Fluorescence Imaging Agent Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Americas Medical Fluorescence Imaging Agent Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Medical Fluorescence Imaging Agent Sales Forecast by Region (2027-2032) & (K Units)
Table 79. APAC Medical Fluorescence Imaging Agent Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Medical Fluorescence Imaging Agent Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Europe Medical Fluorescence Imaging Agent Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Medical Fluorescence Imaging Agent Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Middle East & Africa Medical Fluorescence Imaging Agent Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Medical Fluorescence Imaging Agent Sales Forecast by Type (2027-2032) & (K Units)
Table 85. Global Medical Fluorescence Imaging Agent Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Medical Fluorescence Imaging Agent Sales Forecast by Application (2027-2032) & (K Units)
Table 87. Global Medical Fluorescence Imaging Agent Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. GE Healthcare Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 89. GE Healthcare Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 90. GE Healthcare Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. GE Healthcare Main Business
Table 92. GE Healthcare Latest Developments
Table 93. Bayer AG Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 94. Bayer AG Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 95. Bayer AG Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Bayer AG Main Business
Table 97. Bayer AG Latest Developments
Table 98. Siemens Healthineers Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 99. Siemens Healthineers Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 100. Siemens Healthineers Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Siemens Healthineers Main Business
Table 102. Siemens Healthineers Latest Developments
Table 103. Bracco Imaging S.p.A. Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 104. Bracco Imaging S.p.A. Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 105. Bracco Imaging S.p.A. Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Bracco Imaging S.p.A. Main Business
Table 107. Bracco Imaging S.p.A. Latest Developments
Table 108. Guerbet Group Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 109. Guerbet Group Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 110. Guerbet Group Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Guerbet Group Main Business
Table 112. Guerbet Group Latest Developments
Table 113. Lantheus Medical Imaging Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 114. Lantheus Medical Imaging Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 115. Lantheus Medical Imaging Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Lantheus Medical Imaging Main Business
Table 117. Lantheus Medical Imaging Latest Developments
Table 118. Thermo Fisher Scientific Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 119. Thermo Fisher Scientific Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 120. Thermo Fisher Scientific Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Thermo Fisher Scientific Main Business
Table 122. Thermo Fisher Scientific Latest Developments
Table 123. PerkinElmer, Inc. Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 124. PerkinElmer, Inc. Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 125. PerkinElmer, Inc. Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. PerkinElmer, Inc. Main Business
Table 127. PerkinElmer, Inc. Latest Developments
Table 128. Akorn, Inc. Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 129. Akorn, Inc. Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 130. Akorn, Inc. Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Akorn, Inc. Main Business
Table 132. Akorn, Inc. Latest Developments
Table 133. Nanopet Pharma GmbH Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 134. Nanopet Pharma GmbH Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 135. Nanopet Pharma GmbH Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Nanopet Pharma GmbH Main Business
Table 137. Nanopet Pharma GmbH Latest Developments
Table 138. CMC Contrast AB Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 139. CMC Contrast AB Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 140. CMC Contrast AB Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. CMC Contrast AB Main Business
Table 142. CMC Contrast AB Latest Developments
Table 143. Daiichi Sankyo Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 144. Daiichi Sankyo Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 145. Daiichi Sankyo Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. Daiichi Sankyo Main Business
Table 147. Daiichi Sankyo Latest Developments
Table 148. Spago Nanomedical AB Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 149. Spago Nanomedical AB Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 150. Spago Nanomedical AB Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. Spago Nanomedical AB Main Business
Table 152. Spago Nanomedical AB Latest Developments
Table 153. LI-COR Biosciences Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 154. LI-COR Biosciences Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 155. LI-COR Biosciences Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. LI-COR Biosciences Main Business
Table 157. LI-COR Biosciences Latest Developments
Table 158. BD (Becton, Dickinson and Company) Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 159. BD (Becton, Dickinson and Company) Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 160. BD (Becton, Dickinson and Company) Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 161. BD (Becton, Dickinson and Company) Main Business
Table 162. BD (Becton, Dickinson and Company) Latest Developments
Table 163. Merck KGaA Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 164. Merck KGaA Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 165. Merck KGaA Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 166. Merck KGaA Main Business
Table 167. Merck KGaA Latest Developments
Table 1. Medical Fluorescence Imaging Agent Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Medical Fluorescence Imaging Agent Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Non-Targeted (Passive) Agents
Table 4. Major Players of Targeted Molecular Probes
Table 5. Major Players of Activatable / Smart Probes
Table 6. Global Medical Fluorescence Imaging Agent Sales by Type (2021-2026) & (K Units)
Table 7. Global Medical Fluorescence Imaging Agent Sales Market Share by Type (2021-2026)
Table 8. Global Medical Fluorescence Imaging Agent Revenue by Type (2021-2026) & ($ million)
Table 9. Global Medical Fluorescence Imaging Agent Revenue Market Share by Type (2021-2026)
Table 10. Global Medical Fluorescence Imaging Agent Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Visible-Light Fluorophores
Table 12. Major Players of Near-Infrared (NIR) Fluorophores
Table 13. Global Medical Fluorescence Imaging Agent Sales by Fluorophore Type (2021-2026) & (K Units)
Table 14. Global Medical Fluorescence Imaging Agent Sales Market Share by Fluorophore Type (2021-2026)
Table 15. Global Medical Fluorescence Imaging Agent Revenue by Fluorophore Type (2021-2026) & ($ million)
Table 16. Global Medical Fluorescence Imaging Agent Revenue Market Share by Fluorophore Type (2021-2026)
Table 17. Global Medical Fluorescence Imaging Agent Sale Price by Fluorophore Type (2021-2026) & (US$/Unit)
Table 18. Major Players of Visible-Light Imaging (400–700 nm)
Table 19. Major Players of Near-Infrared I (700–900 nm)
Table 20. Major Players of Near-Infrared II (1000–1700 nm)
Table 21. Global Medical Fluorescence Imaging Agent Sales by Imaging Wavelength (2021-2026) & (K Units)
Table 22. Global Medical Fluorescence Imaging Agent Sales Market Share by Imaging Wavelength (2021-2026)
Table 23. Global Medical Fluorescence Imaging Agent Revenue by Imaging Wavelength (2021-2026) & ($ million)
Table 24. Global Medical Fluorescence Imaging Agent Revenue Market Share by Imaging Wavelength (2021-2026)
Table 25. Global Medical Fluorescence Imaging Agent Sale Price by Imaging Wavelength (2021-2026) & (US$/Unit)
Table 26. Global Medical Fluorescence Imaging Agent Sale by Application (2021-2026) & (K Units)
Table 27. Global Medical Fluorescence Imaging Agent Sale Market Share by Application (2021-2026)
Table 28. Global Medical Fluorescence Imaging Agent Revenue by Application (2021-2026) & ($ million)
Table 29. Global Medical Fluorescence Imaging Agent Revenue Market Share by Application (2021-2026)
Table 30. Global Medical Fluorescence Imaging Agent Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global Medical Fluorescence Imaging Agent Sales by Company (2021-2026) & (K Units)
Table 32. Global Medical Fluorescence Imaging Agent Sales Market Share by Company (2021-2026)
Table 33. Global Medical Fluorescence Imaging Agent Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Medical Fluorescence Imaging Agent Revenue Market Share by Company (2021-2026)
Table 35. Global Medical Fluorescence Imaging Agent Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers Medical Fluorescence Imaging Agent Producing Area Distribution and Sales Area
Table 37. Players Medical Fluorescence Imaging Agent Products Offered
Table 38. Medical Fluorescence Imaging Agent Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Medical Fluorescence Imaging Agent Sales by Geographic Region (2021-2026) & (K Units)
Table 42. Global Medical Fluorescence Imaging Agent Sales Market Share Geographic Region (2021-2026)
Table 43. Global Medical Fluorescence Imaging Agent Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Medical Fluorescence Imaging Agent Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Medical Fluorescence Imaging Agent Sales by Country/Region (2021-2026) & (K Units)
Table 46. Global Medical Fluorescence Imaging Agent Sales Market Share by Country/Region (2021-2026)
Table 47. Global Medical Fluorescence Imaging Agent Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Medical Fluorescence Imaging Agent Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Medical Fluorescence Imaging Agent Sales by Country (2021-2026) & (K Units)
Table 50. Americas Medical Fluorescence Imaging Agent Sales Market Share by Country (2021-2026)
Table 51. Americas Medical Fluorescence Imaging Agent Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Medical Fluorescence Imaging Agent Sales by Type (2021-2026) & (K Units)
Table 53. Americas Medical Fluorescence Imaging Agent Sales by Application (2021-2026) & (K Units)
Table 54. APAC Medical Fluorescence Imaging Agent Sales by Region (2021-2026) & (K Units)
Table 55. APAC Medical Fluorescence Imaging Agent Sales Market Share by Region (2021-2026)
Table 56. APAC Medical Fluorescence Imaging Agent Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Medical Fluorescence Imaging Agent Sales by Type (2021-2026) & (K Units)
Table 58. APAC Medical Fluorescence Imaging Agent Sales by Application (2021-2026) & (K Units)
Table 59. Europe Medical Fluorescence Imaging Agent Sales by Country (2021-2026) & (K Units)
Table 60. Europe Medical Fluorescence Imaging Agent Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Medical Fluorescence Imaging Agent Sales by Type (2021-2026) & (K Units)
Table 62. Europe Medical Fluorescence Imaging Agent Sales by Application (2021-2026) & (K Units)
Table 63. Middle East & Africa Medical Fluorescence Imaging Agent Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa Medical Fluorescence Imaging Agent Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Medical Fluorescence Imaging Agent Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Medical Fluorescence Imaging Agent Sales by Application (2021-2026) & (K Units)
Table 67. Key Market Drivers & Growth Opportunities of Medical Fluorescence Imaging Agent
Table 68. Key Market Challenges & Risks of Medical Fluorescence Imaging Agent
Table 69. Key Industry Trends of Medical Fluorescence Imaging Agent
Table 70. Medical Fluorescence Imaging Agent Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Medical Fluorescence Imaging Agent Distributors List
Table 73. Medical Fluorescence Imaging Agent Customer List
Table 74. Global Medical Fluorescence Imaging Agent Sales Forecast by Region (2027-2032) & (K Units)
Table 75. Global Medical Fluorescence Imaging Agent Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Medical Fluorescence Imaging Agent Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Americas Medical Fluorescence Imaging Agent Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Medical Fluorescence Imaging Agent Sales Forecast by Region (2027-2032) & (K Units)
Table 79. APAC Medical Fluorescence Imaging Agent Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Medical Fluorescence Imaging Agent Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Europe Medical Fluorescence Imaging Agent Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Medical Fluorescence Imaging Agent Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Middle East & Africa Medical Fluorescence Imaging Agent Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Medical Fluorescence Imaging Agent Sales Forecast by Type (2027-2032) & (K Units)
Table 85. Global Medical Fluorescence Imaging Agent Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Medical Fluorescence Imaging Agent Sales Forecast by Application (2027-2032) & (K Units)
Table 87. Global Medical Fluorescence Imaging Agent Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. GE Healthcare Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 89. GE Healthcare Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 90. GE Healthcare Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. GE Healthcare Main Business
Table 92. GE Healthcare Latest Developments
Table 93. Bayer AG Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 94. Bayer AG Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 95. Bayer AG Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Bayer AG Main Business
Table 97. Bayer AG Latest Developments
Table 98. Siemens Healthineers Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 99. Siemens Healthineers Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 100. Siemens Healthineers Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Siemens Healthineers Main Business
Table 102. Siemens Healthineers Latest Developments
Table 103. Bracco Imaging S.p.A. Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 104. Bracco Imaging S.p.A. Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 105. Bracco Imaging S.p.A. Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Bracco Imaging S.p.A. Main Business
Table 107. Bracco Imaging S.p.A. Latest Developments
Table 108. Guerbet Group Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 109. Guerbet Group Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 110. Guerbet Group Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Guerbet Group Main Business
Table 112. Guerbet Group Latest Developments
Table 113. Lantheus Medical Imaging Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 114. Lantheus Medical Imaging Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 115. Lantheus Medical Imaging Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Lantheus Medical Imaging Main Business
Table 117. Lantheus Medical Imaging Latest Developments
Table 118. Thermo Fisher Scientific Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 119. Thermo Fisher Scientific Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 120. Thermo Fisher Scientific Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Thermo Fisher Scientific Main Business
Table 122. Thermo Fisher Scientific Latest Developments
Table 123. PerkinElmer, Inc. Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 124. PerkinElmer, Inc. Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 125. PerkinElmer, Inc. Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. PerkinElmer, Inc. Main Business
Table 127. PerkinElmer, Inc. Latest Developments
Table 128. Akorn, Inc. Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 129. Akorn, Inc. Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 130. Akorn, Inc. Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Akorn, Inc. Main Business
Table 132. Akorn, Inc. Latest Developments
Table 133. Nanopet Pharma GmbH Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 134. Nanopet Pharma GmbH Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 135. Nanopet Pharma GmbH Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Nanopet Pharma GmbH Main Business
Table 137. Nanopet Pharma GmbH Latest Developments
Table 138. CMC Contrast AB Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 139. CMC Contrast AB Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 140. CMC Contrast AB Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. CMC Contrast AB Main Business
Table 142. CMC Contrast AB Latest Developments
Table 143. Daiichi Sankyo Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 144. Daiichi Sankyo Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 145. Daiichi Sankyo Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. Daiichi Sankyo Main Business
Table 147. Daiichi Sankyo Latest Developments
Table 148. Spago Nanomedical AB Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 149. Spago Nanomedical AB Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 150. Spago Nanomedical AB Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. Spago Nanomedical AB Main Business
Table 152. Spago Nanomedical AB Latest Developments
Table 153. LI-COR Biosciences Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 154. LI-COR Biosciences Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 155. LI-COR Biosciences Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. LI-COR Biosciences Main Business
Table 157. LI-COR Biosciences Latest Developments
Table 158. BD (Becton, Dickinson and Company) Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 159. BD (Becton, Dickinson and Company) Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 160. BD (Becton, Dickinson and Company) Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 161. BD (Becton, Dickinson and Company) Main Business
Table 162. BD (Becton, Dickinson and Company) Latest Developments
Table 163. Merck KGaA Basic Information, Medical Fluorescence Imaging Agent Manufacturing Base, Sales Area and Its Competitors
Table 164. Merck KGaA Medical Fluorescence Imaging Agent Product Portfolios and Specifications
Table 165. Merck KGaA Medical Fluorescence Imaging Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 166. Merck KGaA Main Business
Table 167. Merck KGaA Latest Developments
LIST OF FIGURES
Figure 1. Picture of Medical Fluorescence Imaging Agent
Figure 2. Medical Fluorescence Imaging Agent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Medical Fluorescence Imaging Agent Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Medical Fluorescence Imaging Agent Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Medical Fluorescence Imaging Agent Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Medical Fluorescence Imaging Agent Sales Market Share by Country/Region (2025)
Figure 10. Medical Fluorescence Imaging Agent Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Non-Targeted (Passive) Agents
Figure 12. Product Picture of Targeted Molecular Probes
Figure 13. Product Picture of Activatable / Smart Probes
Figure 14. Global Medical Fluorescence Imaging Agent Sales Market Share by Type in 2026
Figure 15. Global Medical Fluorescence Imaging Agent Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Visible-Light Fluorophores
Figure 17. Product Picture of Near-Infrared (NIR) Fluorophores
Figure 18. Global Medical Fluorescence Imaging Agent Sales Market Share by Fluorophore Type in 2026
Figure 19. Global Medical Fluorescence Imaging Agent Revenue Market Share by Fluorophore Type (2021-2026)
Figure 20. Product Picture of Visible-Light Imaging (400–700 nm)
Figure 21. Product Picture of Near-Infrared I (700–900 nm)
Figure 22. Product Picture of Near-Infrared II (1000–1700 nm)
Figure 23. Global Medical Fluorescence Imaging Agent Sales Market Share by Imaging Wavelength in 2026
Figure 24. Global Medical Fluorescence Imaging Agent Revenue Market Share by Imaging Wavelength (2021-2026)
Figure 25. Medical Fluorescence Imaging Agent Consumed in Hospitals & Surgical Centers
Figure 26. Global Medical Fluorescence Imaging Agent Market: Hospitals & Surgical Centers (2021-2026) & (K Units)
Figure 27. Medical Fluorescence Imaging Agent Consumed in Diagnostic Imaging Facilities
Figure 28. Global Medical Fluorescence Imaging Agent Market: Diagnostic Imaging Facilities (2021-2026) & (K Units)
Figure 29. Medical Fluorescence Imaging Agent Consumed in Research Institutions
Figure 30. Global Medical Fluorescence Imaging Agent Market: Research Institutions (2021-2026) & (K Units)
Figure 31. Medical Fluorescence Imaging Agent Consumed in Pharmaceutical R&D Laboratories
Figure 32. Global Medical Fluorescence Imaging Agent Market: Pharmaceutical R&D Laboratories (2021-2026) & (K Units)
Figure 33. Global Medical Fluorescence Imaging Agent Sale Market Share by Application (2025)
Figure 34. Global Medical Fluorescence Imaging Agent Revenue Market Share by Application in 2025
Figure 35. Medical Fluorescence Imaging Agent Sales by Company in 2025 (K Units)
Figure 36. Global Medical Fluorescence Imaging Agent Sales Market Share by Company in 2025
Figure 37. Medical Fluorescence Imaging Agent Revenue by Company in 2025 ($ millions)
Figure 38. Global Medical Fluorescence Imaging Agent Revenue Market Share by Company in 2025
Figure 39. Global Medical Fluorescence Imaging Agent Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global Medical Fluorescence Imaging Agent Revenue Market Share by Geographic Region in 2025
Figure 41. Americas Medical Fluorescence Imaging Agent Sales 2021-2026 (K Units)
Figure 42. Americas Medical Fluorescence Imaging Agent Revenue 2021-2026 ($ millions)
Figure 43. APAC Medical Fluorescence Imaging Agent Sales 2021-2026 (K Units)
Figure 44. APAC Medical Fluorescence Imaging Agent Revenue 2021-2026 ($ millions)
Figure 45. Europe Medical Fluorescence Imaging Agent Sales 2021-2026 (K Units)
Figure 46. Europe Medical Fluorescence Imaging Agent Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa Medical Fluorescence Imaging Agent Sales 2021-2026 (K Units)
Figure 48. Middle East & Africa Medical Fluorescence Imaging Agent Revenue 2021-2026 ($ millions)
Figure 49. Americas Medical Fluorescence Imaging Agent Sales Market Share by Country in 2025
Figure 50. Americas Medical Fluorescence Imaging Agent Revenue Market Share by Country (2021-2026)
Figure 51. Americas Medical Fluorescence Imaging Agent Sales Market Share by Type (2021-2026)
Figure 52. Americas Medical Fluorescence Imaging Agent Sales Market Share by Application (2021-2026)
Figure 53. United States Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC Medical Fluorescence Imaging Agent Sales Market Share by Region in 2025
Figure 58. APAC Medical Fluorescence Imaging Agent Revenue Market Share by Region (2021-2026)
Figure 59. APAC Medical Fluorescence Imaging Agent Sales Market Share by Type (2021-2026)
Figure 60. APAC Medical Fluorescence Imaging Agent Sales Market Share by Application (2021-2026)
Figure 61. China Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 65. India Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe Medical Fluorescence Imaging Agent Sales Market Share by Country in 2025
Figure 69. Europe Medical Fluorescence Imaging Agent Revenue Market Share by Country (2021-2026)
Figure 70. Europe Medical Fluorescence Imaging Agent Sales Market Share by Type (2021-2026)
Figure 71. Europe Medical Fluorescence Imaging Agent Sales Market Share by Application (2021-2026)
Figure 72. Germany Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 73. France Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 74. UK Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa Medical Fluorescence Imaging Agent Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa Medical Fluorescence Imaging Agent Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa Medical Fluorescence Imaging Agent Sales Market Share by Application (2021-2026)
Figure 80. Egypt Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of Medical Fluorescence Imaging Agent in 2026
Figure 86. Manufacturing Process Analysis of Medical Fluorescence Imaging Agent
Figure 87. Industry Chain Structure of Medical Fluorescence Imaging Agent
Figure 88. Channels of Distribution
Figure 89. Global Medical Fluorescence Imaging Agent Sales Market Forecast by Region (2027-2032)
Figure 90. Global Medical Fluorescence Imaging Agent Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global Medical Fluorescence Imaging Agent Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global Medical Fluorescence Imaging Agent Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global Medical Fluorescence Imaging Agent Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global Medical Fluorescence Imaging Agent Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Medical Fluorescence Imaging Agent
Figure 2. Medical Fluorescence Imaging Agent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Medical Fluorescence Imaging Agent Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Medical Fluorescence Imaging Agent Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Medical Fluorescence Imaging Agent Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Medical Fluorescence Imaging Agent Sales Market Share by Country/Region (2025)
Figure 10. Medical Fluorescence Imaging Agent Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Non-Targeted (Passive) Agents
Figure 12. Product Picture of Targeted Molecular Probes
Figure 13. Product Picture of Activatable / Smart Probes
Figure 14. Global Medical Fluorescence Imaging Agent Sales Market Share by Type in 2026
Figure 15. Global Medical Fluorescence Imaging Agent Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Visible-Light Fluorophores
Figure 17. Product Picture of Near-Infrared (NIR) Fluorophores
Figure 18. Global Medical Fluorescence Imaging Agent Sales Market Share by Fluorophore Type in 2026
Figure 19. Global Medical Fluorescence Imaging Agent Revenue Market Share by Fluorophore Type (2021-2026)
Figure 20. Product Picture of Visible-Light Imaging (400–700 nm)
Figure 21. Product Picture of Near-Infrared I (700–900 nm)
Figure 22. Product Picture of Near-Infrared II (1000–1700 nm)
Figure 23. Global Medical Fluorescence Imaging Agent Sales Market Share by Imaging Wavelength in 2026
Figure 24. Global Medical Fluorescence Imaging Agent Revenue Market Share by Imaging Wavelength (2021-2026)
Figure 25. Medical Fluorescence Imaging Agent Consumed in Hospitals & Surgical Centers
Figure 26. Global Medical Fluorescence Imaging Agent Market: Hospitals & Surgical Centers (2021-2026) & (K Units)
Figure 27. Medical Fluorescence Imaging Agent Consumed in Diagnostic Imaging Facilities
Figure 28. Global Medical Fluorescence Imaging Agent Market: Diagnostic Imaging Facilities (2021-2026) & (K Units)
Figure 29. Medical Fluorescence Imaging Agent Consumed in Research Institutions
Figure 30. Global Medical Fluorescence Imaging Agent Market: Research Institutions (2021-2026) & (K Units)
Figure 31. Medical Fluorescence Imaging Agent Consumed in Pharmaceutical R&D Laboratories
Figure 32. Global Medical Fluorescence Imaging Agent Market: Pharmaceutical R&D Laboratories (2021-2026) & (K Units)
Figure 33. Global Medical Fluorescence Imaging Agent Sale Market Share by Application (2025)
Figure 34. Global Medical Fluorescence Imaging Agent Revenue Market Share by Application in 2025
Figure 35. Medical Fluorescence Imaging Agent Sales by Company in 2025 (K Units)
Figure 36. Global Medical Fluorescence Imaging Agent Sales Market Share by Company in 2025
Figure 37. Medical Fluorescence Imaging Agent Revenue by Company in 2025 ($ millions)
Figure 38. Global Medical Fluorescence Imaging Agent Revenue Market Share by Company in 2025
Figure 39. Global Medical Fluorescence Imaging Agent Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global Medical Fluorescence Imaging Agent Revenue Market Share by Geographic Region in 2025
Figure 41. Americas Medical Fluorescence Imaging Agent Sales 2021-2026 (K Units)
Figure 42. Americas Medical Fluorescence Imaging Agent Revenue 2021-2026 ($ millions)
Figure 43. APAC Medical Fluorescence Imaging Agent Sales 2021-2026 (K Units)
Figure 44. APAC Medical Fluorescence Imaging Agent Revenue 2021-2026 ($ millions)
Figure 45. Europe Medical Fluorescence Imaging Agent Sales 2021-2026 (K Units)
Figure 46. Europe Medical Fluorescence Imaging Agent Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa Medical Fluorescence Imaging Agent Sales 2021-2026 (K Units)
Figure 48. Middle East & Africa Medical Fluorescence Imaging Agent Revenue 2021-2026 ($ millions)
Figure 49. Americas Medical Fluorescence Imaging Agent Sales Market Share by Country in 2025
Figure 50. Americas Medical Fluorescence Imaging Agent Revenue Market Share by Country (2021-2026)
Figure 51. Americas Medical Fluorescence Imaging Agent Sales Market Share by Type (2021-2026)
Figure 52. Americas Medical Fluorescence Imaging Agent Sales Market Share by Application (2021-2026)
Figure 53. United States Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC Medical Fluorescence Imaging Agent Sales Market Share by Region in 2025
Figure 58. APAC Medical Fluorescence Imaging Agent Revenue Market Share by Region (2021-2026)
Figure 59. APAC Medical Fluorescence Imaging Agent Sales Market Share by Type (2021-2026)
Figure 60. APAC Medical Fluorescence Imaging Agent Sales Market Share by Application (2021-2026)
Figure 61. China Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 65. India Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe Medical Fluorescence Imaging Agent Sales Market Share by Country in 2025
Figure 69. Europe Medical Fluorescence Imaging Agent Revenue Market Share by Country (2021-2026)
Figure 70. Europe Medical Fluorescence Imaging Agent Sales Market Share by Type (2021-2026)
Figure 71. Europe Medical Fluorescence Imaging Agent Sales Market Share by Application (2021-2026)
Figure 72. Germany Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 73. France Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 74. UK Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa Medical Fluorescence Imaging Agent Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa Medical Fluorescence Imaging Agent Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa Medical Fluorescence Imaging Agent Sales Market Share by Application (2021-2026)
Figure 80. Egypt Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries Medical Fluorescence Imaging Agent Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of Medical Fluorescence Imaging Agent in 2026
Figure 86. Manufacturing Process Analysis of Medical Fluorescence Imaging Agent
Figure 87. Industry Chain Structure of Medical Fluorescence Imaging Agent
Figure 88. Channels of Distribution
Figure 89. Global Medical Fluorescence Imaging Agent Sales Market Forecast by Region (2027-2032)
Figure 90. Global Medical Fluorescence Imaging Agent Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global Medical Fluorescence Imaging Agent Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global Medical Fluorescence Imaging Agent Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global Medical Fluorescence Imaging Agent Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global Medical Fluorescence Imaging Agent Revenue Market Share Forecast by Application (2027-2032)
